nicardipine has been researched along with Angor Pectoris in 65 studies
Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The new calcium antagonist nicardipine was studied for its potency in 73 patients with coronary heart disease concurrent with angina pectoris, including 16 with vasospastic angina." | 9.07 | [Evaluation of antianginal effectiveness of nicardipine in patients with angina pectoris]. ( Guliev, AB; Mironova, IIu; Sidorenko, BA; Sumarokov, AB, 1991) |
| "The two dihydropyridine calcium antagonists, nicardipine and nifedipine, were compared in 12 patients with both stable angina pectoris and systemic hypertension using a double-blind, crossover protocol." | 9.06 | A randomized double-blind crossover study of nicardipine and nifedipine in patients with angina pectoris and concomitant essential hypertension. ( Bonandi, L; Dei Cas, L; Feroldi, P; Metra, M; Nodari, S; Nordio, G; Raddino, R; Visioli, O, 1988) |
| "Nicardipine and nifedipine are structurally similar dihydropyridine calcium channel blockers with demonstrated efficacy in the treatment of stable angina pectoris." | 9.06 | Randomized double-blind comparison of side effects of nicardipine and nifedipine in angina pectoris. The Nicardipine Investigators Group. ( DeWood, MA; Wolbach, RA, 1990) |
| "The dose-related efficacy and safety of nicardipine, a new calcium antagonist of the dihydropyridine class, was assessed by exercise tolerance testing in a randomized, double-blinded, placebo-controlled study in 19 patients with chronic, stable effort angina pectoris." | 9.06 | Efficacy of nicardipine in angina pectoris. ( Giles, TD; Given, MB; Quiroz, AC; Roffidal, LE; Sander, GE; Thomas, MG, 1990) |
| "The antianginal effects of propranolol 160 mg/day, diltiazem 240 mg/day, nicardipine 80 mg/day, nifedipine 40 to 80 mg/day and verapamil 320 mg/day were compared in 12 patients with chronic stable angina pectoris using a symptom-limited exercise test." | 9.06 | Comparison of the antianginal efficacy of four calcium antagonists and propranolol in stable angina pectoris. ( Azzollini, F; Cereda, A; Pelosi, G; Picca, M, 1989) |
| "The comparative effects of prolonged chronic therapy with diltiazem, nicardipine, tiapamil and verapamil on exercise tolerance, ST-segment changes and heart rate were examined in 63 patients with established chronic stable angina pectoris." | 9.06 | Comparative effects of prolonged therapy with four calcium ion antagonists (diltiazem, nicardipine, tiapamil and verapamil) in patients with chronic stable angina pectoris. ( Khurmi, NS; Raftery, EB, 1987) |
| "To determine whether the association of nicardipine with propranolol had additive effects on myocardial metabolism, 16 patients with angina pectoris were studied invasively before and after 1 month of therapy with a combination of nicardipine and propranolol and compared to a group of 42 patients treated with nicardipine (n = 17) or propranolol (n = 25) alone." | 9.06 | Effects of long-term combined dosing with nicardipine and propranolol on coronary hemodynamics, myocardial metabolism, and exercise tolerance in patients with angina pectoris: comparison with monotherapy. ( Hanet, C; Harlow, BJ; Pouleur, H; Rousseau, MF, 1988) |
| "5 and 10mg intravenous nicardipine were measured in 20 male patients with uncomplicated angina pectoris due to angiographically confirmed coronary artery disease." | 9.05 | Haemodynamic effects of intravenous nicardipine during upright exercise in patients with stable angina pectoris. ( Hafizullah, M; Jackson, NC; Reynolds, G; Silke, B; Taylor, SH; Verma, SP, 1984) |
| "Nicardipine, 30 and 40 mg thrice daily, was administered to 66 patients with stable angina pectoris in a multicentre, randomised, double-blind, cross-over trial." | 9.05 | Nicardipine for stable angina pectoris. ( Freedman, D; Hermanovich, J; Lewinter, MM; Scheidt, S; Venkataraman, K, 1985) |
| "Nicardipine is an antagonist of calcium influx through the slow channel of the cell membrane and has been shown to be an effective and relatively well-tolerated treatment for stable effort angina and rest angina due to coronary artery spasm, and mild to moderate hypertension." | 8.77 | Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders. ( Clissold, SP; Sorkin, EM, 1987) |
| "Nicardipine is a new dihydropyridine calcium channel blocking drug with actions that suggest considerable usefulness as an agent for chronic stable angina." | 7.76 | Therapy for angina pectoris: comparison of nicardipine with other antianginal agents. ( Scheidt, S, 1988) |
| "Nicardipine treatment has been evaluated in patients with chronic stable effort angina or with angina at rest due to coronary spasm." | 7.76 | Usefulness of nicardipine for angina pectoris. ( Lambert, CR; Pepine, CJ, 1987) |
| "The effects of the slow calcium channel blocker nicardipine on the synchrony of left ventricular filling were examined in eight patients with angina pectoris." | 7.68 | Effects of nicardipine on regional diastolic left ventricular function in patients with angina pectoris. ( Hanet, C; Pouleur, H; Rousseau, MF; van Eyll, C, 1990) |
| "The effects of the calcium antagonists nicardipine and nisoldipine on left ventricular (LV) metabolism were analyzed in 32 patients with angina pectoris." | 7.67 | Effects of nicardipine and nisoldipine on myocardial metabolism, coronary blood flow and oxygen supply in angina pectoris. ( Charlier, AA; Pouleur, H; Rousseau, MF; Van den Berghe, G; Van Hoof, F; Vincent, MF, 1984) |
| " The average daily dosage of nicardipine for optimal angina relief was 89 mg (range 40 to 160)." | 6.66 | Nicardipine for angina pectoris at rest and coronary arterial spasm. ( Feldman, RL; Gelman, JS; Pepine, CJ; Scott, E, 1985) |
| "When nicardipine was administered after propranolol, the indices of inotropic state were unaffected." | 5.27 | Effects of nicardipine on coronary blood flow, left ventricular inotropic state and myocardial metabolism in patients with angina pectoris. ( Charlier, AA; Cheron, P; Pouleur, H; Rousseau, MF; van den Berghe, G; Vincent, MF, 1985) |
| "Nicardipine is a potent coronary and systemic vasodilating drug that improves exercise tolerance and myocardial metabolic response to pacing stress, the mechanism for which appears to be partially mediated through increased coronary blood flow." | 5.27 | Effects of nicardipine on exercise- and pacing-induced myocardial ischemia in angina pectoris. ( Feldman, RL; Hill, JA; Lambert, CR; Pepine, CJ, 1987) |
| "The new calcium antagonist nicardipine was studied for its potency in 73 patients with coronary heart disease concurrent with angina pectoris, including 16 with vasospastic angina." | 5.07 | [Evaluation of antianginal effectiveness of nicardipine in patients with angina pectoris]. ( Guliev, AB; Mironova, IIu; Sidorenko, BA; Sumarokov, AB, 1991) |
| "Altogether 12 patients with stable angina pectoris of effort were examined for the efficacy of nicardipine as compared to nifedipine and placebo by means of pharmacodynamic studies using treadmill." | 5.06 | [The comparative efficacy of nicardipine and nifedipine in stenocardia patients]. ( Martsevich, SIu; Metelitsa, VI; Simkhaev, LS; Slastnikova, ID, 1990) |
| "To determine whether the association of nicardipine with propranolol had additive effects on myocardial metabolism, 16 patients with angina pectoris were studied invasively before and after 1 month of therapy with a combination of nicardipine and propranolol and compared to a group of 42 patients treated with nicardipine (n = 17) or propranolol (n = 25) alone." | 5.06 | Effects of long-term combined dosing with nicardipine and propranolol on coronary hemodynamics, myocardial metabolism, and exercise tolerance in patients with angina pectoris: comparison with monotherapy. ( Hanet, C; Harlow, BJ; Pouleur, H; Rousseau, MF, 1988) |
| "The two dihydropyridine calcium antagonists, nicardipine and nifedipine, were compared in 12 patients with both stable angina pectoris and systemic hypertension using a double-blind, crossover protocol." | 5.06 | A randomized double-blind crossover study of nicardipine and nifedipine in patients with angina pectoris and concomitant essential hypertension. ( Bonandi, L; Dei Cas, L; Feroldi, P; Metra, M; Nodari, S; Nordio, G; Raddino, R; Visioli, O, 1988) |
| "Nicardipine and nifedipine are structurally similar dihydropyridine calcium channel blockers with demonstrated efficacy in the treatment of stable angina pectoris." | 5.06 | Randomized double-blind comparison of side effects of nicardipine and nifedipine in angina pectoris. The Nicardipine Investigators Group. ( DeWood, MA; Wolbach, RA, 1990) |
| "The dose-related efficacy and safety of nicardipine, a new calcium antagonist of the dihydropyridine class, was assessed by exercise tolerance testing in a randomized, double-blinded, placebo-controlled study in 19 patients with chronic, stable effort angina pectoris." | 5.06 | Efficacy of nicardipine in angina pectoris. ( Giles, TD; Given, MB; Quiroz, AC; Roffidal, LE; Sander, GE; Thomas, MG, 1990) |
| "The antianginal effects of propranolol 160 mg/day, diltiazem 240 mg/day, nicardipine 80 mg/day, nifedipine 40 to 80 mg/day and verapamil 320 mg/day were compared in 12 patients with chronic stable angina pectoris using a symptom-limited exercise test." | 5.06 | Comparison of the antianginal efficacy of four calcium antagonists and propranolol in stable angina pectoris. ( Azzollini, F; Cereda, A; Pelosi, G; Picca, M, 1989) |
| "The comparative effects of prolonged chronic therapy with diltiazem, nicardipine, tiapamil and verapamil on exercise tolerance, ST-segment changes and heart rate were examined in 63 patients with established chronic stable angina pectoris." | 5.06 | Comparative effects of prolonged therapy with four calcium ion antagonists (diltiazem, nicardipine, tiapamil and verapamil) in patients with chronic stable angina pectoris. ( Khurmi, NS; Raftery, EB, 1987) |
| "Nicardipine is currently being evaluated in clinical trials as a treatment for angina and hypertension." | 5.06 | An overview of the safety and efficacy of nicardipine in clinical trials. ( Agre, K, 1987) |
| "5 and 10mg intravenous nicardipine were measured in 20 male patients with uncomplicated angina pectoris due to angiographically confirmed coronary artery disease." | 5.05 | Haemodynamic effects of intravenous nicardipine during upright exercise in patients with stable angina pectoris. ( Hafizullah, M; Jackson, NC; Reynolds, G; Silke, B; Taylor, SH; Verma, SP, 1984) |
| "Nicardipine, 30 and 40 mg thrice daily, was administered to 66 patients with stable angina pectoris in a multicentre, randomised, double-blind, cross-over trial." | 5.05 | Nicardipine for stable angina pectoris. ( Freedman, D; Hermanovich, J; Lewinter, MM; Scheidt, S; Venkataraman, K, 1985) |
| "This study evaluated 1 year the efficacy of therapy with nicardipine in patients with chronic stable angina pectoris." | 5.05 | Short- and long-term treatment of stable effort angina with nicardipine, a new calcium channel blocker: a double-blind, placebo-controlled, randomised, repeated cross-over study. ( Freedman, D; Gheorghiade, M; Schwemer, G; St Clair, C; St Clair, J, 1985) |
| "Nicardipine is an antagonist of calcium influx through the slow channel of the cell membrane and has been shown to be an effective and relatively well-tolerated treatment for stable effort angina and rest angina due to coronary artery spasm, and mild to moderate hypertension." | 4.77 | Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders. ( Clissold, SP; Sorkin, EM, 1987) |
| "Nicardipine is a new dihydropyridine calcium channel blocking drug with actions that suggest considerable usefulness as an agent for chronic stable angina." | 3.76 | Therapy for angina pectoris: comparison of nicardipine with other antianginal agents. ( Scheidt, S, 1988) |
| "Nicardipine treatment has been evaluated in patients with chronic stable effort angina or with angina at rest due to coronary spasm." | 3.76 | Usefulness of nicardipine for angina pectoris. ( Lambert, CR; Pepine, CJ, 1987) |
| "The effects of the slow calcium channel blocker nicardipine on the synchrony of left ventricular filling were examined in eight patients with angina pectoris." | 3.68 | Effects of nicardipine on regional diastolic left ventricular function in patients with angina pectoris. ( Hanet, C; Pouleur, H; Rousseau, MF; van Eyll, C, 1990) |
| "Pharmacokinetic, haemodynamic and radionuclide studies explored the acute pharmacokinetic and pharmacodynamic actions of nicardipine in patients with coronary heart disease." | 3.67 | Pharmacokinetic, haemodynamic and radionuclide studies with nicardipine in coronary artery disease. ( Finlayson, JR; Frais, MA; Graham, DJ; Reynolds, G; Silke, B; Taylor, SH; Verma, SP, 1986) |
| "The effects of the calcium antagonists nicardipine and nisoldipine on left ventricular (LV) metabolism were analyzed in 32 patients with angina pectoris." | 3.67 | Effects of nicardipine and nisoldipine on myocardial metabolism, coronary blood flow and oxygen supply in angina pectoris. ( Charlier, AA; Pouleur, H; Rousseau, MF; Van den Berghe, G; Van Hoof, F; Vincent, MF, 1984) |
| "Nicardipine hydrochloride is an effective, well-tolerated medication for the treatment of stable exertional angina, and is a good alternative to currently available calcium antagonists." | 2.66 | Usefulness of nicardipine as monotherapy for chronic, stable angina. ( Buhite, SG; Dennish, GW; Freedman, D; Giles, T; Glode, J; Koretz, SH; Roe, RL; Sklar, J; Wyskoarko, NP, 1989) |
| " The average daily dosage of nicardipine for optimal angina relief was 89 mg (range 40 to 160)." | 2.66 | Nicardipine for angina pectoris at rest and coronary arterial spasm. ( Feldman, RL; Gelman, JS; Pepine, CJ; Scott, E, 1985) |
| "Nicardipine or saline was randomly infused during the first or second pacing." | 2.66 | Effects of intracoronary infusion of nicardipine during silent ischaemia on myocardial metabolism and function. ( Caucheteux, D; Gurné, O; Hanet, C; Hue, L; Pouleur, H; Rousseau, MF, 1988) |
| "Nicardipine is an effective antianginal agent with an optimal dose of 90 to 120 mg/day." | 2.65 | Short- and long-term efficacy of nicardipine, assessed by placebo-controlled single- and double-blind crossover trials in patients with chronic stable angina. ( Bala Subramanian, V; Bowles, MJ; Khurmi, NS; Raftery, EB, 1984) |
| "Nicardipine was administered as a 200 μg IC bolus, after which repeat angiography was performed." | 1.51 | The Spontaneous Coronary Slow-Flow Phenomenon: Reversal by Intracoronary Nicardipine. ( Finley, JJ; Fischman, DL; McCarey, M; Mehta, HH; Morris, M; Ruggiero, N; Savage, MP; Walinsky, P, 2019) |
| "Nicardipine was administered as a 2 mg bolus followed by an infusion, titrated to maintain a 10 to 20 mm Hg decrease in systolic arterial pressure." | 1.28 | Acute antianginal hemodynamic effects of nicardipine in coronary artery disease. ( Lambert, CR; Pepine, CJ, 1990) |
| "Nicardipine is a powerful arteriodilator without detectable negative inotropic effects and prolongs the time to pacing induced angina." | 1.27 | Effect of nicardipine on left ventricular function and on angina induced by atrial pacing in patients with coronary artery disease. ( Lipkin, DP; Poole-Wilson, PA, 1985) |
| "When nicardipine was administered after propranolol, the indices of inotropic state were unaffected." | 1.27 | Effects of nicardipine on coronary blood flow, left ventricular inotropic state and myocardial metabolism in patients with angina pectoris. ( Charlier, AA; Cheron, P; Pouleur, H; Rousseau, MF; van den Berghe, G; Vincent, MF, 1985) |
| "Nicardipine is a potent coronary and systemic vasodilating drug that improves exercise tolerance and myocardial metabolic response to pacing stress, the mechanism for which appears to be partially mediated through increased coronary blood flow." | 1.27 | Effects of nicardipine on exercise- and pacing-induced myocardial ischemia in angina pectoris. ( Feldman, RL; Hill, JA; Lambert, CR; Pepine, CJ, 1987) |
| "Angina pectoris was prevented on exercise in the majority of patients after intravenous administration." | 1.27 | Immediate and longer-term effects of nicardipine, at rest and during exercise, in patients with coronary artery disease. ( Jaarsma, W; Kan, G; Lie, KI; Visser, CA, 1984) |
| "Nicardipine was administered as a 2 mg bolus (i." | 1.27 | Effects of nicardipine on left ventricular function and energetics in man. ( Feldman, RL; Hill, JA; Lambert, CR; Pepine, CJ, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 50 (76.92) | 18.7374 |
| 1990's | 13 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (3.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mehta, HH | 1 |
| Morris, M | 1 |
| Fischman, DL | 1 |
| Finley, JJ | 1 |
| Ruggiero, N | 1 |
| Walinsky, P | 1 |
| McCarey, M | 1 |
| Savage, MP | 1 |
| Cao, X | 1 |
| Nakamura, Y | 1 |
| Wada, T | 1 |
| Izumi-Nakaseko, H | 1 |
| Ando, K | 1 |
| Zhu, B | 1 |
| Xu, B | 1 |
| Takahara, A | 1 |
| Saitoh, M | 1 |
| Sugiyama, A | 1 |
| Khurmi, NS | 3 |
| Bowles, MJ | 2 |
| Bala Subramanian, V | 2 |
| Raftery, EB | 6 |
| Seu, V | 1 |
| Abrile, PG | 1 |
| Boero, E | 1 |
| Magaia, O | 1 |
| Mocini, A | 1 |
| Castrignano, A | 1 |
| Maffei, P | 1 |
| Perugini, P | 1 |
| Livi, A | 1 |
| Di Pasquale, G | 2 |
| Lusa, AM | 2 |
| Manini, GL | 2 |
| Dominici, P | 1 |
| Coluccini, M | 2 |
| Bassein, L | 2 |
| Pinelli, G | 2 |
| Rousseau, MF | 8 |
| Vincent, MF | 3 |
| Van Hoof, F | 2 |
| Van den Berghe, G | 3 |
| Charlier, AA | 3 |
| Pouleur, H | 8 |
| Jackson, NC | 2 |
| Silke, B | 6 |
| Verma, SP | 6 |
| Reynolds, G | 4 |
| Hafizullah, M | 3 |
| Taylor, SH | 6 |
| Lipkin, D | 1 |
| Poole-Wilson, PA | 2 |
| Visser, CA | 1 |
| Jaarsma, W | 1 |
| Kan, G | 1 |
| Lie, KI | 1 |
| Hopf, R | 1 |
| Becker, HJ | 1 |
| Kober, G | 1 |
| Dowinsky, S | 1 |
| Kaltenbach, M | 1 |
| Connelly, CM | 1 |
| Waksmonski, C | 1 |
| Gagnon, MM | 1 |
| Lipsitz, LA | 1 |
| Das, G | 1 |
| Nukariya, M | 1 |
| Hosoda, Y | 1 |
| Kudou, H | 1 |
| Minami, S | 1 |
| Takazawa, K | 1 |
| Gotou, M | 1 |
| Satoh, T | 1 |
| Kikuchi, N | 1 |
| Watanabe, M | 1 |
| Tahara, M | 1 |
| Parameshwar, J | 1 |
| Keegan, J | 1 |
| Mulcahy, D | 1 |
| Phadke, K | 1 |
| Sparrow, J | 1 |
| Sutton, GC | 1 |
| Fox, KM | 1 |
| Lambert, CR | 5 |
| Zezulka, AV | 1 |
| Sharma, S | 1 |
| Goldhammer, E | 1 |
| Jackson, N | 2 |
| Zharov, EI | 1 |
| Galichenko, IV | 1 |
| Sedov, VP | 1 |
| Martynov, AI | 1 |
| Vertkin, AL | 1 |
| Styrova, TK | 1 |
| Guliev, AB | 1 |
| Sumarokov, AB | 1 |
| Mironova, IIu | 1 |
| Sidorenko, BA | 1 |
| Slastnikova, ID | 1 |
| Martsevich, SIu | 1 |
| Simkhaev, LS | 1 |
| Metelitsa, VI | 1 |
| Hanet, C | 6 |
| van Eyll, C | 2 |
| Pepine, CJ | 5 |
| DeWood, MA | 1 |
| Wolbach, RA | 1 |
| Thomas, MG | 1 |
| Sander, GE | 1 |
| Given, MB | 1 |
| Quiroz, AC | 1 |
| Roffidal, LE | 1 |
| Giles, TD | 1 |
| Picca, M | 1 |
| Azzollini, F | 1 |
| Cereda, A | 1 |
| Pelosi, G | 1 |
| Douard, H | 1 |
| Mora, B | 1 |
| Broustet, JP | 1 |
| Pepine, C | 1 |
| Sklar, J | 1 |
| Dennish, GW | 1 |
| Glode, J | 1 |
| Wyskoarko, NP | 1 |
| Giles, T | 1 |
| Freedman, D | 4 |
| Buhite, SG | 1 |
| Koretz, SH | 1 |
| Roe, RL | 1 |
| Gheorghiade, M | 2 |
| Weiner, DA | 1 |
| Chakko, S | 1 |
| Lessem, JN | 1 |
| Klein, MD | 1 |
| Cheron, P | 1 |
| Frais, MA | 3 |
| Lipkin, DP | 1 |
| Lavenne-Pardonge, E | 1 |
| Harlow, BJ | 1 |
| Scheidt, S | 3 |
| LeWinter, MM | 2 |
| Hermanovich, J | 2 |
| Venkataraman, K | 2 |
| Berland, J | 1 |
| Savin, T | 1 |
| Saoudi, N | 1 |
| Cribier, A | 1 |
| Letac, B | 1 |
| Rodrigues, EA | 3 |
| Lahiri, A | 3 |
| Metra, M | 1 |
| Nodari, S | 1 |
| Nordio, G | 1 |
| Bonandi, L | 1 |
| Raddino, R | 1 |
| Feroldi, P | 1 |
| Dei Cas, L | 1 |
| Visioli, O | 1 |
| Gurné, O | 2 |
| Hue, L | 1 |
| Caucheteux, D | 1 |
| Kohli, RS | 1 |
| Hains, AD | 1 |
| Sorkin, EM | 1 |
| Clissold, SP | 1 |
| Agre, K | 1 |
| Thomassen, AR | 2 |
| Bagger, JP | 3 |
| Nielsen, TT | 3 |
| Allely, MC | 1 |
| Alps, BJ | 1 |
| McGill, D | 1 |
| McKenzie, W | 1 |
| McCredie, M | 1 |
| O'Hara, MJ | 1 |
| Henningsen, P | 2 |
| Hill, JA | 2 |
| Feldman, RL | 3 |
| Pardonge-Lavenne, E | 1 |
| Graham, DJ | 1 |
| Finlayson, JR | 1 |
| Thomassen, A | 1 |
| Hussain, M | 1 |
| Gelman, JS | 1 |
| Scott, E | 1 |
| St Clair, C | 1 |
| St Clair, J | 1 |
| Schwemer, G | 1 |
7 reviews available for nicardipine and Angor Pectoris
| Article | Year |
|---|---|
[Treatment of angina pectoris with calcium antagonists].
Topics: Angina Pectoris; Calcium Channel Blockers; Coronary Disease; Diltiazem; Drug Therapy, Combination; E | 1982 |
Combination therapy with nicardipine and beta-adrenergic blockade for angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Clinical Trials as Topic; Drug Therapy, Combination; H | 1992 |
Nicardipine: another calcium antagonist.
Topics: Angina Pectoris; Humans; Hypertension; Nicardipine | 1989 |
Nicardipine, a new calcium channel blocker: role for vascular selectivity.
Topics: Angina Pectoris; Clinical Trials as Topic; Heart; Heart Conduction System; Humans; Muscle, Smooth, V | 1989 |
Therapy for angina pectoris: comparison of nicardipine with other antianginal agents.
Topics: Angina Pectoris; Clinical Trials as Topic; Hemodynamics; Humans; Nicardipine; Time Factors | 1988 |
Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders.
Topics: Angina Pectoris; Cardiovascular Diseases; Humans; Hypertension; Kinetics; Nicardipine | 1987 |
Usefulness of nicardipine for angina pectoris.
Topics: Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Heart; Humans; Myocardium; Nicardipine; | 1987 |
37 trials available for nicardipine and Angor Pectoris
| Article | Year |
|---|---|
Short- and long-term efficacy of nicardipine, assessed by placebo-controlled single- and double-blind crossover trials in patients with chronic stable angina.
Topics: Adult; Aged; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Metho | 1984 |
[Preliminary note on the use of calcium antagonists in ischemic cardiopathy].
Topics: Adult; Angina Pectoris; Benzazepines; Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; | 1984 |
Comparative efficacy of nicardipine, a new calcium antagonist, versus nifedipine in effort stable angina.
Topics: Aged; Angina Pectoris; Double-Blind Method; Drug Evaluation; Exercise Test; Female; Humans; Male; Mi | 1984 |
Comparative efficacy of nicardipine, a new calcium antagonist, versus nifedipine in stable effort angina.
Topics: Aged; Angina Pectoris; Calcium Channel Blockers; Double-Blind Method; Drug Administration Schedule; | 1984 |
Haemodynamic effects of intravenous nicardipine during upright exercise in patients with stable angina pectoris.
Topics: Adult; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Heart Rate; Hemody | 1984 |
Effect of nicardipine on myocardial contractility and on angina induced by atrial pacing in patients with coronary artery disease (abstract).
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Cardiac Pacing, Artificial; | 1984 |
Effects of isosorbide dinitrate and nicardipine hydrochloride on postprandial blood pressure in elderly patients with stable angina pectoris or healed myocardial infarction.
Topics: Aged; Angina Pectoris; Blood Pressure; Cross-Over Studies; Double-Blind Method; Eating; Female; Huma | 1995 |
[Effect of nicardipine cardioplegia on A-V conduction system in coronary bypass surgery].
Topics: Angina Pectoris; Coronary Artery Bypass; Diltiazem; Heart Conduction System; Humans; Middle Aged; Ni | 1994 |
Atenolol or nicardipine alone is as efficacious in stable angina as their combination: a double blind randomised trial.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Double-Blind Method; Drug Therapy, Combination; Exercise; Fe | 1993 |
How does posture influence the haemodynamic assessment of a cardiovascular drug? Experience with nicardipine.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Cardiac Output; Cardiovascular Agents; Coronary Diseas | 1990 |
[Evaluation of antianginal effectiveness of nicardipine in patients with angina pectoris].
Topics: Angina Pectoris; Electrocardiography; Electrocardiography, Ambulatory; Exercise Test; Humans; Nicard | 1991 |
[The comparative efficacy of nicardipine and nifedipine in stenocardia patients].
Topics: Angina Pectoris; Chronic Disease; Coronary Disease; Electrocardiography; Exercise Test; Humans; Male | 1990 |
Randomized double-blind comparison of side effects of nicardipine and nifedipine in angina pectoris. The Nicardipine Investigators Group.
Topics: Adult; Angina Pectoris; Dizziness; Double-Blind Method; Edema; Flushing; Foot Diseases; Headache; Hu | 1990 |
Efficacy of nicardipine in angina pectoris.
Topics: Aged; Angina Pectoris; Blood Pressure; Double-Blind Method; Electrocardiography; Exercise Test; Hear | 1990 |
Comparison of the antianginal efficacy of four calcium antagonists and propranolol in stable angina pectoris.
Topics: Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Double-Blind Method; | 1989 |
Comparison of the anti-anginal efficacy of nicardipine and nifedipine in patients receiving atenolol: a randomized, double-blind, crossover study.
Topics: Angina Pectoris; Atenolol; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Syner | 1989 |
Nicardipine, a new calcium channel blocker: role for vascular selectivity.
Topics: Angina Pectoris; Clinical Trials as Topic; Heart; Heart Conduction System; Humans; Muscle, Smooth, V | 1989 |
Usefulness of nicardipine as monotherapy for chronic, stable angina.
Topics: Adult; Angina Pectoris; Blood Pressure; Chronic Disease; Double-Blind Method; Drug Administration Sc | 1989 |
Monotherapy of stable angina with nicardipine hydrochloride: double-blind, placebo-controlled, randomized study.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Chronic Disease; Double-Blind Method; Electrocardiogra | 1989 |
Myocardial protection by intracoronary nicardipine administration during percutaneous transluminal coronary angioplasty.
Topics: Angina Pectoris; Angioplasty, Balloon; Coronary Disease; Coronary Vessels; Epoprostenol; Humans; Hyp | 1987 |
Effects of long-term combined dosing with nicardipine and propranolol on coronary hemodynamics, myocardial metabolism, and exercise tolerance in patients with angina pectoris: comparison with monotherapy.
Topics: Adult; Aged; Angina Pectoris; Cardiac Pacing, Artificial; Clinical Trials as Topic; Double-Blind Met | 1988 |
Efficacy and safety of nicardipine for chronic, stable angina pectoris: a multicenter randomized trial.
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; M | 1986 |
Comparative effects of prolonged therapy with four calcium ion antagonists (diltiazem, nicardipine, tiapamil and verapamil) in patients with chronic stable angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Calcium Channel Blockers; Chronic Disease; Diltiazem; Female; Humans; | 1987 |
A randomized double-blind crossover study of nicardipine and nifedipine in patients with angina pectoris and concomitant essential hypertension.
Topics: Adult; Angina Pectoris; Blood Pressure; Double-Blind Method; Heart; Humans; Hypertension; Male; Midd | 1988 |
Effects of intracoronary infusion of nicardipine during silent ischaemia on myocardial metabolism and function.
Topics: Adult; Aged; Angina Pectoris; Cardiac Catheterization; Coronary Disease; Glutamine; Heart; Hemodynam | 1988 |
Comparison of nicardipine and verapamil in the management of chronic stable angina.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Double-Bli | 1988 |
Therapy for angina pectoris: comparison of nicardipine with other antianginal agents.
Topics: Angina Pectoris; Clinical Trials as Topic; Hemodynamics; Humans; Nicardipine; Time Factors | 1988 |
Usefulness of nicardipine for angina pectoris.
Topics: Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Heart; Humans; Myocardium; Nicardipine; | 1987 |
An overview of the safety and efficacy of nicardipine in clinical trials.
Topics: Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; | 1987 |
Comparison of nicardipine and propranolol for chronic stable angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Metho | 1986 |
Randomized double-blind placebo-controlled comparison of nicardipine and nifedipine in patients with chronic stable angina pectoris.
Topics: Aged; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Method; Exer | 1986 |
Improvement in left ventricular diastolic function in patients with stable angina after chronic treatment with verapamil and nicardipine.
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Diastole; Double-Blind Method; Female; Heart Functio | 1987 |
Comparative haemodynamic effects of nicardipine and verapamil in coronary artery disease.
Topics: Adult; Angina Pectoris; Calcium Channel Blockers; Coronary Artery Bypass; Exercise Test; Hemodynamic | 1985 |
Nicardipine for angina pectoris at rest and coronary arterial spasm.
Topics: Aged; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Vasospasm; Doubl | 1985 |
Nicardipine for stable angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Exercise Test; Female; Heart | 1985 |
Short- and long-term treatment of stable effort angina with nicardipine, a new calcium channel blocker: a double-blind, placebo-controlled, randomised, repeated cross-over study.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Do | 1985 |
Haemodynamic analysis of the effects of nicardipine and metoprolol alone and in combination in coronary artery disease.
Topics: Adult; Angina Pectoris; Calcium Channel Blockers; Coronary Disease; Drug Therapy, Combination; Femal | 1985 |
24 other studies available for nicardipine and Angor Pectoris
| Article | Year |
|---|---|
The Spontaneous Coronary Slow-Flow Phenomenon: Reversal by Intracoronary Nicardipine.
Topics: Adult; Angina Pectoris; Cohort Studies; Coronary Angiography; Coronary Artery Disease; Coronary Circ | 2019 |
Comparison of anti-anginal effect of cilnidipine with those of nicardipine and nifedipine in the vasopressin-induced angina model of rats.
Topics: Angina Pectoris; Animals; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Calciu | 2016 |
Effects of nicardipine and nisoldipine on myocardial metabolism, coronary blood flow and oxygen supply in angina pectoris.
Topics: Aged; Angina Pectoris; Calcium Channel Blockers; Coronary Circulation; Hemodynamics; Humans; Lactate | 1984 |
Immediate and longer-term effects of nicardipine, at rest and during exercise, in patients with coronary artery disease.
Topics: Aged; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Coronary Disease; F | 1984 |
Calcium channel blockers in chronic stable angina. A review.
Topics: Angina Pectoris; Calcium Channel Blockers; Chronic Disease; Diltiazem; Electrocardiography; Humans; | 1982 |
Severe generalized hyperkinesia to nicardipine SR therapy.
Topics: Aged; Angina Pectoris; Delayed-Action Preparations; Diazepam; Dyskinesia, Drug-Induced; Humans; Male | 1994 |
[Effects of nicardipine in silent myocardial ischemia].
Topics: Adult; Angina Pectoris; Coronary Disease; Drug Evaluation; Electrocardiography; Heart; Humans; Male; | 1991 |
Effects of nicardipine on regional diastolic left ventricular function in patients with angina pectoris.
Topics: Angina Pectoris; Cardiac Output; Cineangiography; Electrocardiography; Female; Humans; Male; Middle | 1990 |
Acute antianginal hemodynamic effects of nicardipine in coronary artery disease.
Topics: Aged; Angina Pectoris; Cardiac Pacing, Artificial; Coronary Disease; Exercise; Hemodynamics; Humans; | 1990 |
Nicardipine--a new calcium-entry blocker.
Topics: Angina Pectoris; Costs and Cost Analysis; Drug Interactions; Hemodynamics; Humans; Hypertension; Myo | 1989 |
Effects of nicardipine on coronary blood flow, left ventricular inotropic state and myocardial metabolism in patients with angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Calcium Channel Blockers; Coronary Circul | 1985 |
Effects of nicardipine on cardiac volume at rest and during exercise-induced angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Cardiac Volume; Dose-Respons | 1985 |
Effect of nicardipine on left ventricular function and on angina induced by atrial pacing in patients with coronary artery disease.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Calcium Channel Blockers; Cardiac Pacing, | 1985 |
[Systemic and coronary hemodynamic effects of intravenous nicardipine at rest and in ischemia induced by rapid atrial stimulation].
Topics: Adult; Angina Pectoris; Cardiac Pacing, Artificial; Coronary Circulation; Coronary Disease; Female; | 1987 |
Improvement in left ventricular diastolic function in patients with stable angina after chronic treatment with verapamil and nicardipine.
Topics: Adult; Aged; Angina Pectoris; Diastole; Female; Humans; Male; Middle Aged; Myocardial Contraction; N | 1988 |
Hemodynamic and cardiac metabolic changes during nicardipine-induced myocardial ischemia.
Topics: Angina Pectoris; Coronary Disease; Electrocardiography; Exercise Test; Hemodynamics; Humans; Male; M | 1988 |
The effects of the novel anti-anginal compound RS 43285 on myocardial conduction in the anaesthetized dog.
Topics: Acetanilides; Anesthesia; Angina Pectoris; Animals; Atrioventricular Node; Dogs; Electrocardiography | 1988 |
Dose-related haemodynamic effects of nicardipine during rest and exercise and variable anti-anginal effects in patients with chronic stable angina.
Topics: Angina Pectoris; Dose-Response Relationship, Drug; Hemodynamics; Humans; Nicardipine; Physical Exert | 1987 |
Effects of nicardipine on exercise- and pacing-induced myocardial ischemia in angina pectoris.
Topics: Angina Pectoris; Cardiac Catheterization; Cardiac Pacing, Artificial; Coronary Circulation; Coronary | 1987 |
Changes in myocardial metabolism during therapy in patients with chronic stable angina: a comparison of long-term dosing with propranolol and nicardipine.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Cardiac Pacing, Artificial; Chronic Disease; Exercise | 1986 |
Pharmacokinetic, haemodynamic and radionuclide studies with nicardipine in coronary artery disease.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Cardiac Output; Coronary Disease; Heart Rate; Hemodyna | 1986 |
Impaired regional diastolic distensibility in coronary artery disease: relations with dynamic left ventricular compliance.
Topics: Adult; Angina Pectoris; Coronary Circulation; Coronary Disease; Humans; Middle Aged; Myocardial Cont | 1986 |
Metabolic and hemodynamic effects of nicardipine during pacing-induced angina pectoris.
Topics: Alanine; Angina Pectoris; Blood Pressure; Cardiac Catheterization; Cardiac Pacing, Artificial; Citra | 1987 |
Effects of nicardipine on left ventricular function and energetics in man.
Topics: Angina Pectoris; Calcium Channel Blockers; Cardiac Output; Coronary Circulation; Coronary Disease; H | 1986 |